Viawealth LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,242 shares of the healthcare conglomerate’s stock after selling 136 shares during the period. UnitedHealth Group makes up 2.2% of Viawealth LLC’s holdings, making the stock its 10th biggest holding. Viawealth LLC’s holdings in UnitedHealth Group were worth $3,664,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. iA Global Asset Management Inc. increased its stake in UnitedHealth Group by 9.6% in the fourth quarter. iA Global Asset Management Inc. now owns 186,814 shares of the healthcare conglomerate’s stock valued at $94,502,000 after purchasing an additional 16,366 shares in the last quarter. Magnetar Financial LLC increased its stake in UnitedHealth Group by 124.0% in the fourth quarter. Magnetar Financial LLC now owns 72,227 shares of the healthcare conglomerate’s stock valued at $36,537,000 after purchasing an additional 39,988 shares in the last quarter. Teacher Retirement System of Texas increased its stake in UnitedHealth Group by 28.8% in the fourth quarter. Teacher Retirement System of Texas now owns 391,768 shares of the healthcare conglomerate’s stock valued at $198,180,000 after purchasing an additional 87,662 shares in the last quarter. First Financial Bankshares Inc increased its stake in UnitedHealth Group by 0.3% in the fourth quarter. First Financial Bankshares Inc now owns 38,193 shares of the healthcare conglomerate’s stock valued at $19,320,000 after purchasing an additional 112 shares in the last quarter. Finally, Generali Investments Management Co LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at $2,258,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
UnitedHealth Group Stock Down 0.1 %
UNH opened at $503.05 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $460.14 billion, a price-to-earnings ratio of 32.45, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company’s 50-day moving average price is $510.48 and its two-hundred day moving average price is $548.22.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.67%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. KeyCorp reissued an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $629.32.
Get Our Latest Research Report on UnitedHealth Group
Insider Activity at UnitedHealth Group
In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is currently owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- How to start investing in penny stocks
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Short Selling: How to Short a Stock
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What is a Dividend King?
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.